Publisher Correction: Orthogonal Cas9-Cas9 chimeras provide a versatile platform for genome editing

Mehmet Fatih Bolukbasi; Pengpeng Liu; Kevin Luk; Samantha F Kwok; Ankit Gupta; Nadia Amrani; Erik J Sontheimer; Lihua Julie Zhu; Scot A Wolfe

doi:10.1038/s41467-018-07776-9

Publisher Correction: Orthogonal Cas9-Cas9 chimeras provide a versatile platform for genome editing

Nat Commun. 2018 Dec 10;9(1):5294. doi: 10.1038/s41467-018-07776-9.

Authors

Mehmet Fatih Bolukbasi^{1

2

3}, Pengpeng Liu¹, Kevin Luk¹, Samantha F Kwok¹, Ankit Gupta^{1

4}, Nadia Amrani⁵, Erik J Sontheimer^{5

6}, Lihua Julie Zhu^{1

6

7}, Scot A Wolfe^{8

9}

Affiliations

¹ Department of Molecular, Cell and Cancer Biology, University of Massachusetts Medical School, Worcester, MA, USA.
² Department of Biochemistry and Molecular Pharmacology, University of Massachusetts Medical School, Worcester, MA, USA.
³ Exonics Therapeutics, Watertown, MA, USA.
⁴ Bluebird Bio., Cambridge, MA, USA.
⁵ RNA Therapeutics Institute, University of Massachusetts Medical School, Worcester, MA, USA.
⁶ Program in Molecular Medicine, University of Massachusetts Medical School, Worcester, MA, USA.
⁷ Program in Bioinformatics and Integrative Biology, University of Massachusetts Medical School, Worcester, MA, USA.
⁸ Department of Molecular, Cell and Cancer Biology, University of Massachusetts Medical School, Worcester, MA, USA. scot.wolfe@umassmed.edu.
⁹ Department of Biochemistry and Molecular Pharmacology, University of Massachusetts Medical School, Worcester, MA, USA. scot.wolfe@umassmed.edu.

Abstract

The original version of this Article contained errors in the author affiliations. Mehmet Fatih Bolukbasi was incorrectly associated with Bluebird Bio., Cambridge, MA, USA and Ankit Gupta was incorrectly associated with Exonics Therapeutics, Watertown, MA, USA. This has now been corrected in the HTML version of the Article. The PDF version of the Article was correct at the time of publication.

Publication types

Published Erratum